Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Prostate Adenocarcinoma × PROSTVAC × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostate Adenocarcinoma 1

Interventions

atezolizumab 1 PROSTVAC 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04020094 2021-09-22

AtezoVax

University of Utah

Phase 2 Withdrawn

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡